10 Best Gene Therapy Stocks to Buy Right Now
Gene therapy is referred to as a medical technique that involves modifying or manipulating genes to treat or prevent disease.
Bluebird Bio Inc. (BLUE)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 147,175 | $1,227,440 | 0% | ||
| 2. | Avidity Partners Management David Witzke And Michael Gregory | 81,555 | $680,169 | 0.06% | |
| 3. | Lion Point Didric Cederholm | 78,912 | $658,126 | 3.44% | |
| 4. | Partner Fund Management Christopher Medlock James | 75,758 | $631,822 | 0.03% | |
| 5. | Masters Capital Management Mike Masters | 48,750 | $406,575 | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $52.26 | 4,781 | Officer, Director | 17,186 | 2015-12-08 | Filing | |
| $51.25 | 4,901 | Officer, Director | 12,405 | 2015-12-08 | Filing | |
| $85.00 | 1,176 | Director | 1,176 | 2014-12-19 | Filing | |
| $85.00 | 2,352 | Director | 5,293 | 2014-12-19 | Filing | |
| $34.00 | 2,941 | Director | 2,941 | 2014-07-14 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $7.39 | 122 | 8,378 | 2025-02-03 | Filing | ||
| $7.39 | 64 | 8,194 | 2025-02-03 | Filing | ||
| $7.39 | 238 | 4,501 | 2025-02-03 | Filing | ||
| $7.39 | 86 | 18,485 | 2025-02-03 | Filing | ||
| $9.24 | 19 | 8,257 | 2025-01-06 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 3,851,700 | $32,123,178 | 0.07% | |
| 2. | 708,669 | $5,910,299 | 0% | |
| 3. | 525,414 | $4,381,953 | 0% | |
| 4. | 250,500 | $2,089,170 | 0% | |
| 5. | 233,514 | $1,947,932 | 0% |
News See All
bluebird bio, Inc. (NASDAQ:BLUE) Q3 2024 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen. Thank you for standing by. Welcome to bluebird bio's Third Quarter 2024 Results Conference Call. At this time, all participants are in a listen-only mode.
10 Most Promising Gene Editing Stocks to Buy According to Hedge Funds
The pharmaceutical industry remains a hub of patent innovation, driven by evolving treatment paradigms, unmet medical needs, and the rising influence of technologies like pharmacogenomics, digital therapeutics...
bluebird bio, Inc. (NASDAQ:BLUE) Q2 2024 Earnings Call Transcript
Operator: Thank you for standing by. My name is Ken and I will be your conference operator today. At this time, I would like to welcome everyone to the bluebird bio Second Quarter 2024 Results Call.
bluebird bio, Inc. (NASDAQ:BLUE) Q1 2024 Earnings Call Transcript
Before we begin, let me review our safe harbor statement.
bluebird bio, Inc. (NASDAQ:BLUE) Q4 2023 Earnings Call Transcript
Operator: Good day, and welcome to bluebird bio Fourth Quarter and 2023 Annual Results Conference Call. At this time all participants are in a listen-only mode.
5 Best Medical Stocks to Buy Under $10
In this article, we will take a look at the 5 best medical stocks to buy under $10.
5 Best 52-Week Low Stocks To Buy Now
Goldman Sachs recently said in its Americas Retail report for 2024 that retailers that offer ideas in "categories that consumers continue to prioritize" could gain in the year.
bluebird bio, Inc. (NASDAQ:BLUE) Q3 2023 Earnings Call Transcript
Operator: Good day, ladies and gentlemen, and thank you for standing by. Welcome to the bluebird bio Third Quarter 2023 Results Conference Call.
5 Best Affordable Stocks To Buy Under $5
In this article, we discuss 5 best affordable stocks to buy under $5.
Billionaire Hedge Funds
